Yamamoto, Mako

In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration

Suzuki, K., Tsunekawa, Y., Hernandez-Benitez, R., Wu, J., Zhu, J., Kim, E. J., Hatanaka, F., Yamamoto, M., Araoka, T., Li, Z., et al. (2016) · Nature

CRISPR and Genetic EngineeringRNA regulation and disease

Cited by 1,150

In vivo partial reprogramming alters age-associated molecular changes during physiological aging in mice.

Browder, K. C., Reddy, P., Yamamoto, M., Haghani, A., Guillen, I. G., Sahu, S., Wang, C., Luque, Y., Prieto, J., Shi, L., et al. (2022) · Nature Aging

Pluripotent Stem Cells ResearchTelomeres, Telomerase, and Senescence

Cited by 253

LINE-1 RNA causes heterochromatin erosion and is a target for amelioration of senescent phenotypes in progeroid syndromes

Della Valle, F., Reddy, P., Yamamoto, M., Liu, P., Saera-Vila, A., Bensaddek, D., Zhang, H., Prieto Martinez, J., Abassi, L., Celii, M., et al. (2022) · Science Translational Medicine

Telomeres, Telomerase, and SenescenceNuclear Structure and Function

Cited by 127